GoodRx is a compelling small-cap value play with stabilizing growth, expanding pharma partnerships, and potential acquisition ...

Ladies and gentlemen, thank you for standing by and welcome to the GoodRx First Quarter 2025 Earnings ... do not relate to matters of historical fact should be considered forward-looking ...

We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at ...

Insurance challenges leave millions of Americans frustrated when trying to fill prescriptions. The bureaucratic obstacles not only exacerbate delays, but often translate to more of the cost burden ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on GoodRx Holdings GDRX ... This supplementary information provides further guidance for ...

GoodRx, which specializes in prescription and telehealth services, saw its revenue rise by almost 3% year-over-year to just under $203 million. Non-GAAP (adjusted) net income also advanced ...

Get the annual and quarterly balance sheet of GoodRx Holdings, Inc. (GDRX) including details of assets, liabilities and shareholders' equity.

GoodRx launched in 2011, and since then, it has helped Americans save more than $85 billion on medication costs, according to the Santa Monica, Calif.-based company. What's next for managed care ...

Pharmaceuticals are among the most tested, analyzed and scrutinized consumer products in the world. Initial laboratory ...